Wilson Sonsini Goodrich & Rosati advised Boundless Bio on IP matters related to the transaction.Boundless Bio, a clinical-stage, next-generation precision oncology company developing innovative therapeutics directed…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
